Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
June 24, 2024 03:00 ET
|
Acino International AG
Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...
Acino significantly expands presence and capabilities in Latin America through acquisition of M8 Pharmaceuticals
September 20, 2023 07:59 ET
|
Acino International AG
Zurich, Switzerland, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Acino, a Swiss pharmaceutical company headquartered in Zurich, today announced that it has entered into an agreement to acquire M8...
Acino acquires selected Aspen brands in South Africa
October 22, 2021 02:17 ET
|
Acino International AG
Zurich, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ZURICH, Switzerland, 22 October 2021 - Acino and Aspen Pharmacare Holdings Limited and its subsidiaries (collectively, “Aspen”) have signed an agreement for...